IPH4502 is a novel and differentiated topoisomerase I inhibitor ADC designed to precisely target Nectin-4, a cell adhesion ...

SHANGHAI, Jan. 9, 2025 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced a significant milestone for its proprietary Nectin-4 ...

SHANGHAI, Jan. 9, 2025 /PRNewswire/ -- Mabwell (688062), an innovative biopharmaceutical company with entire industry chain, announced a significant milestone for its proprietary Nectin-4 targeted ...

Quebec’s health department is warning people who may have been exposed to measles in several regions of the province to monitor for symptoms amid a new outbreak of the disease. Marie-Pierre ...

This study demonstrates the utility of Nectin-4-targeted positron emission tomography (PET) imaging using [68Ga]AJ647 as a non-invasive tool for real-time assessment of target engagement in enfortumab ...

Aberrant expression of nectin-4 (N4) has emerged as a promising therapeutic target, leading to the FDA's first anti-N4 ADC approval of Enfortumab vedotin for the treatment of patients with locally ...

SHANGHAI, China I January 9, 2025 I Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced a significant milestone for its proprietary Nectin-4 targeted ADC ...

SEATAC, Wash. — There are now two confirmed cases of measles exposure in Snohomish County. This news from Snohomish County Public Health came just after Public Health - Seattle & King County was ...